Issue 12, 2018

Synthesis and physicochemical characterizations of coordination between palladium(ii) metal ions with floroquinolone drugs as medicinal model against cancer cells: novel metallopharmaceuticals

Abstract

Three new complexes of palladium(II) floroquinolone drugs (levofloxacin (HLVX), pefloxacin mesylate (HPFX) and lomefloxacin (HLMX)) were prepared in alkaline media at pH = 9. The suggested chemical formula was assigned as [Pd(L)2] (where L = LVX, PFX and LMX). These complexes were explored by elementary analyses, conductivity tests, infrared and proton NMR spectroscopy, and thermogravimetric analysis and its deferential tools. The homogeneity, surface morphology and particle size of the as-synthesized solid palladium(II) complex were investigated using X-ray powder diffraction and transmittance electron microscopy. FT-IR and 1H-NMR spectroscopy techniques. The results reveal that HLVX, HPFX and HLMX fluoroquinolones act as bidentate chelates coordinated to the palladium(II) central metal ion via the oxygen of carboxylate and carbonyl groups. The palladium(II) metal ion produces a stable six-membered ring with distorted octahedral structure. The conductivity measurement results deduced that these chelates are non-electrolytic in 1 : 2 stoichiometric ratio. Thermal analysis (TG/DTG) was applied to ascertain the stability of the as-synthesized complexes in comparison to free floroquinolone drugs. The thermal decomposition pathways show that the final residual product is pure PdO. Thermodynamic parameters such as energy of activation E*, entropy ΔS*, enthalpy ΔH* and Gibbs free energy ΔG* of activation were calculated using Coats–Redfern and Horowitz–Metzger non-isothermal techniques. The particle sizes of palladium(II) complexes were measured within nanoscale range, dependent on morphological tools (XRD and TEM). Molecular docking assessment of the three floroquinolones against prostate cancer mutant 2q7k-hormone receptor is discussed. To our knowledge, this paper presents the first-time synthesis and physicochemical characterizations of a coordination complex of palladium(II) metal ions with floroquinolone and its use as a medicinal model against cancer cells.

Graphical abstract: Synthesis and physicochemical characterizations of coordination between palladium(ii) metal ions with floroquinolone drugs as medicinal model against cancer cells: novel metallopharmaceuticals

Supplementary files

Article information

Article type
Paper
Submitted
03 Mar 2018
Accepted
21 Apr 2018
First published
23 Apr 2018

New J. Chem., 2018,42, 9709-9719

Synthesis and physicochemical characterizations of coordination between palladium(II) metal ions with floroquinolone drugs as medicinal model against cancer cells: novel metallopharmaceuticals

S. M. El-Megharbel, M. S. Hegab, E. A. Manaaa, J. Y. Al-Humaidi and M. S. Refat, New J. Chem., 2018, 42, 9709 DOI: 10.1039/C8NJ01045E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements